Related Experiment Videos
Hyperfractionated, twice-a-day, radiotherapy may decrease IQ deterioration due to prophylactic cranial irradiation in
S Vijayakumar1, R Muller-Runkel
1Department of Radiation and Cellular Oncology, Michael Reese/University of Chicago, IL 60616.
Medical Hypotheses
|July 1, 1992
Summary
Aggressive chemotherapy cures most childhood acute lymphoblastic leukemia (ALL). However, cranial irradiation to prevent leukemia spread can harm IQ. Hyper-fractionated radiotherapy, given twice daily, may reduce this delayed toxicity.
Area of Science:
- Pediatric Oncology
- Radiation Oncology
- Neuro-oncology
Background:
- Childhood acute lymphoblastic leukemia (ALL) has high cure rates with current treatments.
- Prophylactic cranial irradiation is used to treat sanctuary sites in ALL.
- IQ deterioration is a significant late complication of prophylactic cranial irradiation.
Purpose of the Study:
- To propose a hyper-fractionated radiotherapy schedule for prophylactic cranial irradiation in childhood ALL.
- To investigate the potential of reducing delayed toxicity, specifically IQ deterioration, by altering radiotherapy fractionation.
Main Methods:
- Radiobiological models suggest that separating acute and late tissue responses is possible with hyper-fractionation.
- The proposed method involves administering radiotherapy twice daily.
- A prospective clinical trial is needed for confirmation.
Main Results:
- Current radiobiological models favor a hyper-fractionated treatment scheme.
- The study hypothesizes that hyper-fractionation can decrease delayed toxicity.
Conclusions:
- Hyper-fractionated radiotherapy is a promising strategy to mitigate IQ deterioration after prophylactic cranial irradiation in childhood ALL.
- Prospective clinical trials are essential to validate the efficacy of this approach in preventing or reducing IQ decline.